BRIDGEBIO PHARMA INC. - COMMON STOCK
23.42
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.18
+0.77%
Today's range
22.47 - 23.65
ISIN
N/A
Source
NASDAQ
-
22 Nov 2024 19:11:30 By Nasdaq GlobeNewswire
-
18 Nov 2024 11:15:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Third Quarter 2024 Financial Results and Business Update
12 Nov 2024 07:30:01 By Nasdaq GlobeNewswire
-
05 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
24 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
17 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 16:45:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 16:45:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
30 Aug 2024 10:50:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in September Investor Events
28 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Launches MyAchonJourney, a New Resource for Families Navigating Achondroplasia
19 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
01 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer
23 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >